long term continuous infusion ch14.18/CHO
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for long term continuous infusion ch14.18/CHO, covering 2020-07-14 to 2020-07-14. Get the full timeline:
Most recent: Clinical Trial Update: Long Term Continuous Infusion ch14.18/CHO Plus s.c. Aldesleukin (IL-2) [Phase 1, Phase 2]